ÂÜÀòÂÒÂ×

Friedrich von Bohlen, Ph.D., is co-founder and managing director of dievini Hopp BioTech holding GmbH & Co. KG. dievini manages the biotech activities and investments of SAP co-founder Dietmar Hopp and his family. Dr. von Bohlen holds a graduate degree (Diplom) in Biochemistry from the University of Zurich and a Ph.D. in Neurobiology from the Swiss Federal Institute of Technology in Zurich, Switzerland. From 1992 to 1997, he worked for Fresenius AG, FAG Kugelfischer, and WASAG-Chemie AG. In 1997, he founded LION bioscience AG (now Expedion AG) and served as the company’s CEO for six years. In addition to serving as Chairman of the Supervisory Board for Apogenix, Dr. von Bohlen holds several other board positions in dievini Hopp portfolio companies.